Industry sources put the first four weeks at about 129,800 won wholesale, roughly half of Mounjaro's starting cost. Launch is expected later this month.
Recap by typeshit. Full story at Korea JoongAng Daily.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
Novo Nordisk is cutting what Wegovy costs in China, Polskie Radio reports. Tap through for the size of the cut and when it takes effect.
Medscape reports national data showing the January 2026 pill launch picked up faster early than injectable tirzepatide or semaglutide did.
A short social clip with an unnamed GLP-1 expert. The listing doesn't say which topics they get into.
Loading…